Eli Lilly Corp. sell Snowman
Start price
25.03.21
/
50%
€152.98
Target price
25.09.21
€140.00
Performance (%)
25.83%
End price
28.06.21
€192.50
Summary
This prediction ended on 28.06.21 with a price of €192.50. The SELL prediction by Snowman finished with a performance of 25.83%. Dividends of €0.70 are taken into consideration when calculating the performance. Snowman has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eli Lilly Corp. | -3.513% | -3.513% | 92.507% | 333.280% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
According to Snowman what are the pros and cons of Eli Lilly Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Known brand
Medium risks for its business
Some uniques
Innovative
Top 10 in its market
Future proof or reliable business model
Cons
overvalued
Comments by Snowman for this prediction
In the thread Eli Lilly Corp. diskutieren
Sell mit Kursziel 140,0